These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19542465)

  • 1. LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline.
    Bergsson G; Reeves EP; McNally P; Chotirmall SH; Greene CM; Greally P; Murphy P; O'Neill SJ; McElvaney NG
    J Immunol; 2009 Jul; 183(1):543-51. PubMed ID: 19542465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis.
    Reeves EP; Williamson M; O'Neill SJ; Greally P; McElvaney NG
    Am J Respir Crit Care Med; 2011 Jun; 183(11):1517-23. PubMed ID: 21330456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum.
    Bucki R; Byfield FJ; Janmey PA
    Eur Respir J; 2007 Apr; 29(4):624-32. PubMed ID: 17215317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo.
    Scott A; Weldon S; Buchanan PJ; Schock B; Ernst RK; McAuley DF; Tunney MM; Irwin CR; Elborn JS; Taggart CC
    PLoS One; 2011; 6(10):e26525. PubMed ID: 22028895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.
    Weldon S; McNally P; McElvaney NG; Elborn JS; McAuley DF; Wartelle J; Belaaouaj A; Levine RL; Taggart CC
    J Immunol; 2009 Dec; 183(12):8148-56. PubMed ID: 20007580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial Peptide LL-37 Is Both a Substrate of Cathepsins S and K and a Selective Inhibitor of Cathepsin L.
    Andrault PM; Samsonov SA; Weber G; Coquet L; Nazmi K; Bolscher JG; Lalmanach AC; Jouenne T; Brömme D; Pisabarro MT; Lalmanach G; Lecaille F
    Biochemistry; 2015 May; 54(17):2785-98. PubMed ID: 25884905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin.
    Weiner DJ; Bucki R; Janmey PA
    Am J Respir Cell Mol Biol; 2003 Jun; 28(6):738-45. PubMed ID: 12600826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis.
    Chen CI; Schaller-Bals S; Paul KP; Wahn U; Bals R
    J Cyst Fibros; 2004 Mar; 3(1):45-50. PubMed ID: 15463886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D represses rhinovirus replication in cystic fibrosis cells by inducing LL-37.
    Schögler A; Muster RJ; Kieninger E; Casaulta C; Tapparel C; Jung A; Moeller A; Geiser T; Regamey N; Alves MP
    Eur Respir J; 2016 Feb; 47(2):520-30. PubMed ID: 26585423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model.
    Bals R; Weiner DJ; Meegalla RL; Wilson JM
    J Clin Invest; 1999 Apr; 103(8):1113-7. PubMed ID: 10207162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the decoy molecule PA401 on CXCL8 levels in bronchoalveolar lavage fluid of patients with cystic fibrosis.
    McElvaney OJ; O'Reilly N; White M; Lacey N; Pohl K; Gerlza T; Bergin DA; Kerr H; McCarthy C; O'Brien ME; Adage T; Kungl AJ; Reeves EP; McElvaney NG
    Mol Immunol; 2015 Feb; 63(2):550-8. PubMed ID: 25453468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of markers of inflammation and infection in induced sputum in children with cystic fibrosis.
    Ordoñez CL; Kartashov AI; Wohl ME
    J Pediatr; 2004 Nov; 145(5):689-92. PubMed ID: 15520781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
    Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
    Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine concentrations and neutrophil elastase activity in bronchoalveolar lavage and induced sputum from patients with cystic fibrosis, mild asthma and healthy volunteers.
    McGarvey LP; Dunbar K; Martin SL; Brown V; Macmahon J; Ennis M; Elborn JS
    J Cyst Fibros; 2002 Dec; 1(4):269-75. PubMed ID: 15463826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.
    Malhotra S; Hayes D; Wozniak DJ
    J Cyst Fibros; 2019 Nov; 18(6):796-803. PubMed ID: 31036488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific cleavage of the lung surfactant protein A by human cathepsin S may impair its antibacterial properties.
    Lecaille F; Naudin C; Sage J; Joulin-Giet A; Courty A; Andrault PM; Veldhuizen RA; Possmayer F; Lalmanach G
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1701-9. PubMed ID: 23707200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BPI-ANCA is expressed in the airways of cystic fibrosis patients and correlates to platelet numbers and Pseudomonas aeruginosa colonization.
    Hovold G; Lindberg U; Ljungberg JK; Shannon O; Påhlman LI
    Respir Med; 2020; 170():105994. PubMed ID: 32843162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis.
    Brivio A; Conese M; Gambazza S; Biffi A; Tirelli AS; Russo M; Foà M; Colombo C
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):482-489. PubMed ID: 27149365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of cathelicidin processing in Papillon-Lefèvre syndrome patients reveals essential role of LL-37 in periodontal homeostasis.
    Eick S; Puklo M; Adamowicz K; Kantyka T; Hiemstra P; Stennicke H; Guentsch A; Schacher B; Eickholz P; Potempa J
    Orphanet J Rare Dis; 2014 Sep; 9():148. PubMed ID: 25260376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic antimicrobial peptides promote microbial mutagenesis and pathoadaptation in chronic infections.
    Limoli DH; Rockel AB; Host KM; Jha A; Kopp BT; Hollis T; Wozniak DJ
    PLoS Pathog; 2014 Apr; 10(4):e1004083. PubMed ID: 24763694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.